BioCentury
ARTICLE | Clinical News

Burixafor: Phase I/II started

May 11, 2015 7:00 AM UTC

TaiGen began an open-label, dose-finding, Chinese Phase I/II trial to evaluate burixafor in combination with fludarabine and cytarabine chemotherapy in up to 15 patients. ...